%e3%82%af%e3%83%ad%e3%82%b5%e3%82%ae%e5%86%8d%e8%b5%b7%e5%8b%95%2c%e2%80%93%2craw%2c%e3%80%90%e7%ac%ac2%e8%a9%b1%e3%80%91%2c%e3%82%af%e3%83%ad%e3%82%b5%e3%82%ae%e5%86%8d%e8%b5%b7%e5%8b%95%2c%e2%80%93%2craw%2c%e3%80%90%e7%ac%ac2%e8%a9%b1%e3%80%91%2craw%2cfr -

The tension ramps up as two major characters—Kurosaki and the white swindler Shiraishi—unexpectedly run into each other, a dynamic that longtime readers have missed.

The legendary "Black Swindler" is back! Following the massive success of the original series and multiple live-action adaptations, the new manga short series (Kurosagi Restart: 18-Year-Old New Adult Fraud Crimes Arc) has arrived to tackle modern-day scams. Chapter 2 Highlights: A Blast from the Past

The Kurosagi Saikidou one-shot volume is available via Shogakukan and various digital platforms like BookLive . The tension ramps up as two major characters—Kurosaki

The Kurosagi Saikidou series was launched in Big Comic Spirits to coincide with the starring Sho Hirano (Number_i). While the original manga concluded in 2013, this short 7-chapter run serves as a timely update on how fraud has evolved in the digital and "new adult" era. How to Read and Watch

In Chapter 2, titled "The 18-Year-Old New Adult Fraud Arc (Part 2)," the story continues its focus on the exploitation of Japan’s lowered age of adulthood. Chapter 2 Highlights: A Blast from the Past

Whether you are a "veteran reader" (ko-san dokusha) recognizing the hidden cameos or a newcomer following the drama, Kurosagi Saikidou Chapter 2 proves that Kurosaki's "weapon against fraud" is as sharp as ever.

For those who prefer the live-action drama, both the 2006 version (starring Tomohisa Yamashita) and the 2022 version (starring Sho Hirano) are available to stream on Netflix as of early 2025. How to Read and Watch In Chapter 2,

Fans of the original series were treated to a special moment. Author Kuromaru revealed on X (formerly Twitter) that a specific scene in Chapter 2 is a "self-homage" to a previous arc in Shin Kurosagi Vol. 4 regarding "Medical Corporation Fraud".